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Antibodies that bind to nucleic acids, ribonucleoproteins, and cytoskeletal
proteins are characteristic of systemic lupus erythematosus (SLE) and several
other autoimmune diseases (1). The source of these autoantibodies has been
sought by immunochemical, idiotypic, and structural analyses (reviewed in 2),
but whether an exogenous antigen or defective immunoregulation accounts for
their production is unknown. An important clue about their origin is that anti-
DNA mAbs have the frequently observed property of polyreactivity, i.e., the
ability to bind to more than one nuclear or cytoplasmic antigen. A polyreactive
monoclonal lupus autoantibody can bind to both DNA and cytoskeletal proteins
(3), to both DNA and the Sm ribonucleoprotein antigen (4), to several different
polynucleotides and phospholipids (5), or to DNA and polypeptides on cell
membranes (6). Polyreactivity is also a feature ofmonoclonal autoantibodies that
bind to specific components of different organs of the endocrine system (7).
Some mAbs with reactivity against nucleic acid antigens also bind to exogenous
antigens like bacterial polysaccharides (8) and organic chemical haptens (9);
reviewed in (10). These unusual crossreactions are immunochemically specific:
the binding of anti-DNA mAbs to bacterial polysaccharides is inhibited only by
polysaccharides with particular sugar linkages (8), and reciprocal inhibition of
ligand binding occurs in competition assays performed with DNA and TNP (9).
These kinds of binding specificities for both autoantigens and exogenous
antigens may provide additional clues about the origins of autoantibodies. We
wondered whether such dual reactivity implies a physiological relationship be-
tween autoantibodies and antibodies against exogenous antigens. Diamond and
Scharff(11) showed that a mutation in the V gene ofthe myeloma protein S107
(glu 35 replaced by ala) led to a loss ofthe antibody's phosphorylcholine-binding
activity and a gain in its ability to bind to DNA and cardiolipin. Their finding
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raises the possibility that autoantibodies arise by mutation of genes that encode
antibacterial antibodies.
In the experiments reported here, we tested an alternative hypothesis about
the origins of autoantibodies; namely, that unmutated germline V genes ex-
pressed by preimmune B cells are a source ofautoantibodies. Such autoantibodies
could give rise to antibodies against exogenous antigens by mutation and antigen
selection . To test this hypothesis, we analyzed the antigen-binding properties of
antibodies produced during the course of the immune response of normal mice
to the hapten p-azophenyl arsonate (Ars). Antibodies produced by hybridomas
that were selected by a DNA probe for the VHIdCR gene were studied. This gene
segment encodes the idiotype termed IdCR (or CRI-A), which dominates the
immune response of A/J mice to Ars (12). The development ofV,, gene diversity
by somatic mutation after Ars immunization has been studied in detail (13), but
the antigenic specificities of the preimmune (nonmutated) repertoire of antibod-
ies encoded by the VIdCR gene are unknown. We show here that a high
proportion of members of the preimmune antibody repertoire of this antihapten
system react with DNA and cytoskeletal proteins. Of 26 antibodies encoded by
the unmutated VIdCR gene, 50% bound to DNA . Furthermore, Ars immuni-
zation seemed to divert the autoreactivity of preimmune antibodies to Ars-
reactivity. The apparent conversion was probably due to somatic mutation of
VId`'R followed by specific selection of high-affinity anti-Ars antibodies from a
pool of autoreactive precursors.
Materials and Methods
Antigens.
￿
The synthetic polynucleotides poly(I) and poly(dT) were purchased from P.
L. Biochemicals, Milwaukee, WI, and Collaborative Research, Waltham, MA. Native
DNA (nDNA), single-stranded DNA (ssDNA),' and RNA were prepared as described
previously (14). Ars-KLH and Ars-tyrosine were prepared as described previously (12).
Antibodies.
￿
mAbs from unimmunized A/J mice were obtained from hybridomas that
were prepared after in vitro stimulation of spleen cells with either LPS or goat anti-
mouse IgM . mAbs from immunized A/J mice were obtained from hybridomas prepared
after one or two injections of Ars-KLH. H130 is an anti-DNA mAb produced by a
hybridoma from an MRL lpr/lpr mouse (15); TEPC 183 was purchased from Litton
Bionetics, Charleston, SC ; and pooled normal mouse immunoglobulin was purchased
from Cappel Laboratories, Cochranville, PA.
Screening and Selection of Hybridomas.
￿
All of the A/J hybridoma antibodies were
derived and structurally characterized in earlier studies. Group I hybridomas were derived
by fusion of mitogen-stimulated spleen cells from nonimmune A/J mice, and were selected
on the basis of production of mRNA homologous to the VIdcR DNA probe as reported
(16). Partial sequences of J, D, and V regions were determined by the method of
Kaartinen et al . (17). >2,000 nucleotides of sequence obtained in this way from preimmune
hybridomas revealed no somatic mutations (13 and T. Manser, unpublished results).
Group II hybridomas (primary immune response) were obtained in fusions performed
within 9 d after single immunizations with Ars-KLH as reported (16). With the exceptions
of P65L9-2 and P65L9-3, all hybridomas were isolated on the basis of their production
of antibody that binds to a rabbit antiserum which recognizes the strain A major
crossreactive idiotype. The two exceptions were selected in a screen that detects mRNA
homologous to the VId"R probe (18). Antibodies synthesized by these hybridomas have
thus far shown no somatic mutations. A total of ^-1,500 nucleotides of mRNA sequence
revealed no change from the germlineJ and VId" gene segments (16) . Included in the
' Abbreviation used in this paper:
￿
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sequenced samples were the most strongly DNA-binding antibodies, P65H3-1 and P6514-
1, including the complete VId' CDR-2 region in each case.
Hybridomas in group III were isolated from fusions of A/J spleen cells after two
immunizations with Ars. Members of the hvH65 series were selected on the basis of
VIdc' mRNA production as reported, (16, 17), and the others by serological criteria
(19-22). Groups I V and V hybridomas produce antibodies that are not encoded by the
VId" gene segment and have been described elsewhere (16, 22, 23).
Ligand-binding Assays.
￿
mAbs were tested for their ability to bind to ssDNA by means
of an ELISA (8). The polynucleotide was diluted to a concentration of 3.0,ug/ml in Tris
buffered saline (TBS), and 150 yl of the solution was added to poly-L-lysine-coated plates;
after 2 h the plates were washed three times with Tris-buffered saline. The plates were
then blocked with poly-L-glutamate and stored at 4°C for at least 12 h. The wells were
blocked with phosphate-EDTA buffer containing 1% BSA for 30 min at 23°C before
addition of the antibody to the coated wells. The plate was washed with PBS containing
0.1 % Tween-20; goat anti-mouse Ig conjugated to alkaline phosphatase was then added,
and the plate was incubated overnight at 23°C. Determination of bound alkaline phos-
phatase was performed as described previously (8). Reaction of the antibodies with Ars
was examined by RIA using Ars-BSA on the solid phase (24). The affinity of the reaction
was measured by fluorescence quenching (24).
For competitive immunoassays, equal volumes of the mAb and various dilutions of the
inhibitor (polynucleotide, Ars-tyrosine, or antiidiotype) were mixed and incubated for 1
h at 37°C, and then at 4°C overnight. The mixtures were tested by ELISA for their
residual binding to the plate.
Immunofuorescence Assays.
￿
Human fibroblasts (GM 0152 cell line; Institute For Med-
ical Research, Camden, NJ) grown on coverslips were obtained just before confluence
and fixed for 5 min in methanol at -20° C. These cellsand HEP2 cells (Bion, Park Ridge,
IL) were incubated in 40 ul of the antibody, at a concentration of 100 'Ug/ml, in a humid
chamber for 45 min at 20°C. The cells were washed in PBS and then stained with a
fluorescein-labeled IgG fraction of a goat anti-mouse Ig serum (Cappel Laboratories) at
a 1 :20 dilution of the original antibody protein concentration of 10 mg/ml. The prepa-
rations were examined with fluorescence epiillumination. Magnification in all photographs
is 600 x.
Results
Binding of VId"-encoded Antibodies to DNA.
￿
We studied 44 mAbs that had
been obtained from hybridomas of A/J origin (Table I). Of the 37 hybridomas
that expressed the VIdIR gene, 10 were derived from unimmunized A/J mice
(group I) ; 12 were obtained after a single injection of Ars-KLH (group II); and
15 were derived after two injections of Ars-KLH (group III). The hybridomas
in groups I-III were selected by screening with either a DNA probe that detects
the germline gene VId`'R or by a serological method that detects the VId`'R
gene product. The two antibodies in group IV were selected by screening
hybridomas with a DNA probe for the VIdss-so gene . Five other antibodies were
coded by unrelated V genes (group V). Reactions with ssDNA in a solid-phase
ELISA were found with 14 antibodies: 7 of 10 in group I, 3 of the 12 in group
II, and 4 of 15 in group III (Table I) . The 10 anti-DNA antibodies from groups
I and II are partially encoded by the nonmutated germline VHId" gene (16).
None of the anti-DNA antibodies of group I had detectable binding to Ars. The
three group II anti-DNA antibodies bound to Ars with only low affinity, and
none of them was encoded by a mutated VIdCR gene. Four IgG antibodies from
group III bound ssDNA; three were encoded by nonmutated VIdCR genes, and
the gene that encoded the fourth had few mutations. One of the group III anti-TABLE I
Characteristics ofHybridoma Proteins
Ars immunization is designated by 0 (none), + (one injection of Ars-KLH), or ++ (two injections of Ars-KLH). All antibodies in
groups 1, II, and III are encoded by the VxldcK gene that partially encodes the major Id"". Antibodies in group IV are encoded by
the VH36-60 gene segment that partially encodes the minor Id 36-60. Antibodies in group V are encoded by VH gene segments
other than VHIdcK or Vi{ld'sso. Controls include H130, an anti-DNA mAb derived from MRL 1pr/1ßr mice (15); TEPC 183, a
monoclonal myelomaprotein that binds toneither Arsnor DNA; and pooled normal mouse immunoglobulins (mlg). V gene segments
are designated as follows: C, the D or VK region gene segments that are coexpressed with VHIdr' to form the majority of anti-Ars
antibodies expressed during the secondary strain A anti-Ars response; *, a D or VK region gene segment that differs substantially
from C; C'", the VH, D, or VK region gene segment used to encode the minor idiotype (Id"o) ofthestrain A anti-Ars response. The
V gene segments of H130 were identified by K. Barrett (Tufts University). The degree ofsomatic mutation in the VHldc" region is
designated as follows: No, no evidence for somatic mutation resulting in amino acid replacements has been found by direct mRNA
sequencing, NHs-terminal amino acid sequencing, or both; Loin, evidence for limited mutational alteration (62% amino acid
substitution); Med, 2-5% amino acid substitutions; High, >5% amino acid substitution. The reaction with Ars was examined by RIA
using Ars-BSA on the solid phase ([0], no detectable binding). The affinity of the reaction with Ars-tyrosine was measured by
fluorescence quenching analysis, and the K, is expressed in liters/mole . The reaction of the antibodies with DNA was studied by
direct binding to ssDNA in a solid-phase ELISA. The number indicates the reciprocal (per microgram) of the amount ofantibody
with anti-DNA activity that was equivalent to that of 0.75 wg of the anti-DNA mAb H130. 0 indicates that 15 Mg of the tested
antibody had less anti-DNA activity than that of0.75 vg of H130. The reaction with cytoskeletal structures was studied by indirect
immunofluorescence (see legend to Fig. 2). 0, no immunofluorescence detected; + to ++++ indicate increasing degrees of
immunofluorescence.
$ An antinuclear pattern.
Protein Ars immuniza-
tion
Isotype
V
VHIdcK
region
D
gene segments
Jx VK JK
VH muta-
[ions
Ars binding
(liters/
mole)
ssDNA
binding
Immuno-
fluores-
cence
Group I
hVH65-a5 0 IgM, k + 4 ? ? No 0 6.7 ND
hVH65-8 0 IgM, k + 4 * 4 No 0 2.7 +++
hVH65-22 0 IgM, k + 3 * ? No 0 2.7 +++$
hVH65-25 0 IgM, k + 3 5 No 0 2.7 +
hVH65-21 0 IgM, k + 2 ' 4 No 0 0.1 ND
hVH65-17 0 IgM, k + 3 t No 0 0.2 ++
hVH65-5 0 IgM, k + 1 ' 1 No 0 0.1 ND
hVH65-a1 0 IgM, k + 3 ' 1 No 0 0 0
hVH65-a2 0 IgM,? + 2 ? ? No 0 0 0
hVH65-20 0 IgM, k + 4 " 4 No 0 0 0
Group II
P65D6-3 + IgM, k + C 2 C 1 No 4.5 x 105 0.50 +++
P65H3-1 + IgM, k + " 3 ' ' No <5 X 104 11,1 +
P6514-1 + IgM, k + ' 2 * ' No <5 x 10' 1.9 +
P65D6-2 + IgM, k + ' 4 C 1 No <los 0 0
P65D6-5 + IgG2a, k + C 2 C 1 No 5.6 X 10' 0 0
P6514-2 + IgG3,k + C 2 C 1 No <5 x 104 0 0
P6567-2 + IgGI, k + ? 4 C 1 No <105 0 0
P65J4-I + IgG3, k + C 2 C 1 No los 0 0
P65L9-3 + IgG2a, k + ? 1 ' * No <5 x 104 0 0
P65L9-2 + IgGI, k + * I C 1 No 4 x 105 0 0
P65C6-3 + IgG26, k + ? 4 C 1 No <los 0 0
P6567-1 + IgGI,k + * 4 C 1 No <I05 0 0
Group 111
bVH65-205 ++ IgG3,? + ' 3 ? ? No 0 0,1 +
36-65 ++ IgGI, k + C 2 C 1 No 4 X 105 0.4 ++++
44-10 ++ IgGI, k + C 2 C ? No 5 X 105 0.2 +
bVH65-219 ++ IgG26, k + * 2 C 1 Low 1 .2 x 105 0.8 +
45-49 ++ IgGI, k + ' 2 C 1 High >106 0 0
hVH65-202 ++ IgG26, k + ' 2 C 1 No 2.5 X 105 0 0
hVH65-207 ++ 1gG1,k + C 2 C 1 Med lol 0 0
liVH65-208 ++ IgG, k + C 2 C 1 High 1.6 x 10' 0 ND
bVH65-209 ++ IgGI, k + 2 c 1 Med 9.5 X lol 0 0
bVH65-211 ++ IgG3, k + C 2 C 1 Low lol 0 0
hVH65-212 ;+ IgGI, k + C 2 C 1 Med 3.6 X 10' 0 0
31-62 ++ IgG2a, k + ? 2 C ? Low 106 0 ++
36-71 ++ IgGI, k + C 2 C ? Med 4.5 x 10' 0 0
I6-46 ++ IgG2a, k + ? ? ? Low + 0 0
45-248 ++ IgM, k + ? 2 ? ? Low 1.7 X 10' 0 ND
Group IV
36-60 ++ IgG2a, k (C,) Cm 3 Cm ? Low 1,4 X 10' 0 0
36-54 ++ IgM, k (C,) Cm 3 Cm ? Low 1.3 X 10' 0 0
Group V
45-112 ++ IgGI, k 0 107 0 ND
hVH60-10 ++ IgM,? 0 3 0 0 0
hVH65-2 ++ IgM, k 0 4 0 0 0
hVH65-7 ++ IgM, k 0 2 0 0 0
.W3 ++ IgM, k 0 4 0 0 ND
Controls
H130 0 IgM, k ND 1.3 +++
TEPC 183 0 IgM, k 0 0 0
mlg 0 0 0 0618
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Inhibition of the binding of mAb hVH65-22 to ssDNA by polynucleotides. The
reaction of hVH65-22 with ssDNA on the solidphase (0.45 ug/well) was examined by ELISA
after preincubation of the Ig with increasing amounts of ssDNA, native DNA (nDNA), RNA,
and poly(I). Poly(I) and ssDNA, but not RNA inhibited the bindingof hVH65-22 to ssDNA.
nDNA wasa poor inhibitor. Inhibitorconcentration is expressed in micromolar phosphate.
DNA antibodies, hVH65-205, had no anti-Ars activity . Another anti-DNA
antibody in group III was 36-65, the prototypic Id" antibody of the anti-Ars
response of A/J mice (21). Antibodies with the minor Ars idiotype (Ides-so, group
IV) and other, unrelated anti-Ars antibodies (group V) did not bind to DNA.
The specificity of the reaction with ssDNA was tested by competitive liquid-
phase immunoassays (Fig. 1). ssDNA, but not RNA, a similarly charged nucleic
acid, inhibited the DNAbindingofall the anti-DNA antibodies. Threeantibodies
(hVH65-8, hVH65-22, and hVH65-25) were also tested in liquid-phase compet-
itive assays with the synthetic polynucleotide poly(I), and with double-stranded
DNA. Poly(I) completely inhibited the DNA binding of all three antibodies,
whereas double-stranded DNA was only weakly inhibitory .
Immunofluorescence Analysis. One anti-DNA mAb of group I (hVH65-22)
gave a typical homogeneous antinuclear staining pattern, as well as a reaction
with cytoskeletal fibers when tested with human fibroblasts (Fig. 2A). This
pattern of dual nuclear and cytoplasmic reactivity has been found with mAbs
derived from humans with SLE or from lupus-prone MRL lpr/lpr mice (3). 10
other anti-DNA antibodies also bound to cytoskeletal structures . Two antibodies
bound to stress fibers (actin) in both human fibroblasts and HEP2 cells; the other
eight produced immunofluorescent patterns on HEP2 substrates that were
consistent with prekeratin and vimentin (Fig. 2B). When tested with human
fibroblasts, those eight antibodies bound to vimentin and desmin filaments, as
well as to tubulin (Fig. 2 C). When colcemid-treated human fibroblasts were used
as a substrate, these antibodies bound to thick perinuclear whorls, consistent
with collapsed fibers of vimentin and desmin (Fig. 2D). Concordance between
anti-DNA binding and immunofluorescent staining was found in all but one case,
31-62, which did not react with DNA but bound to cytoskeletal fibers (Table I).
Relationship Between Ars Binding and DNA Binding. Six of the antibodies
bound to both Ars and DNA (Table I). The affinity of their binding to Ars-
tyrosine was relatively low (K <5 X 104-5 X 10'/M). The ability of Ars-tyrosine
to inhibit the reactions of these antibodies with DNA was tested (Fig. 3). Ars-
tyrosine inhibited the binding of antibodies 44-10 and 36-65 (group III) to
ssDNA (50% inhibition was achieved at 100 and 150 AM, respectively), but it
did not inhibit the binding of P65H3-1 or P65I4-1 (group 11, very low-affinityFIGURE 2 . Immunofluorescent staining patterns . A, Concomitant staining of the nuclei
(homogeneous pattern) and cytoplasmic fibers (vimentin) of human fibroblasts by antibody
hVH65-22 . B, Staining of cytoplasmic intermediate filaments (keratin and vimentin), and
possibly tubulin by antibody hHv65-8 (HEP2 cells) . C, Human fibroblasts with staining of
desmin, vimentin fibers, and possibly tubulin by antibody hVH65-25 . D, Reaction of antibody
hVH65-17 with human fibroblasts treated with colcemid (5,ug/ml for 18 h) . Thick perinuclear
whorls characteristic of the disruption of vimentin anddesmin by the drug are seen . All figures
x 450 .
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FIGURE 3 .
￿
Inhibition of the binding of mAbs to DNA by Ars-tyrosine . The reaction of
various anti-DNA mAbs with ssDNAon the solid phase (0.45,ug/well) was examined by ELISA
after preincubation of the Igs with increasing amounts of Ars-tyrosine . The reactions of
antibodies 44-10 and 35-65 with DNA, but not those of antibodies P65H3-1, hVH65-22, and
H130, were inhibited by Ars-tyrosine .
619
anti-Ars antibodies) . The hapten conjugate had no effect on the DNA binding
of antibodies hVH65-8, hHV65-22, and H130, which did not bind Ars-tyrosine .
The binding oftwo chimeric proteins (25) to ssDNA was also tested . The Ars-
binding chimera, composed of wild type heavy chain variable region sequences620
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FIGURE 4.
￿
Inhibition of the binding of mAbs to DNA by antiidiotypic antibody AD8. The
reaction of various mAbs with ssDNA on the solid phase was examined by ELISA after
preincubation of the Igs with various dilutions of ascitic fluid of the ADS hybridoma. The
reactionsof antibodies P65I4-1, hVH65-22, and 36-65with DNA, butnot thoseof H130 and
44-10 were inhibitedby the antiidiotypic antibody.
identical to those of the 36-65 antibody (a V.C. chain paired with a V,C, chain),
also bound to ssDNA . By contrast, the chimeric protein containing a single V
amino acid substitution (ala for ser in residue 99) that was generated by in vitro
mutagenesis and has reduced Ars-binding ability (J. Sharon, manuscript in
preparation), did not bind to ssDNA .
Relationship Between Id`'R and the DNA Binding Site.
￿
The capacity of an anti-
Id" mAb (AD8) (25) to inhibit the DNA binding of six IdcR+ antibodies was
tested. The antiidiotypic antibody inhibited the DNA binding of antibodies 36-
65, hVH65-22, P65I4-1, P65H3-1, and hVH65-219 (Fig. 4). The binding to
DNA of antibodies 44-10 (group III) and H130 (group V), both of which lack
the idiotype detected by AD8, was unaffected by the antiidiotype.
Discussion
These experiments show that an unmutated germline Vt, gene segment that is
expressed by preimmune B cells can encode antibodies with the typical antigen-
binding properties of lupus autoantibodies. Of the 10 mAbs that had been
selected by their usage of the VIdc' gene segment and obtained before immu-
nization with Ars-KLH, 7 were found to bind to polynucleotide antigens and to
cytoskeletal proteins. And of the 27 VIdc'-encoded mAbs obtained after im-
munization with Ars-KLH, 6 bound to DNA and cytoskeletal proteins as well as
to Ars. Three of those six antibodies originated from mice that had been injected
with Ars-KLH only once ; they had the IgM isotype and their VIdcR genes were
not mutated. The other three antibodies, derived from mice that were immu-
nized with Ars-KLH twice, had the IgG isotype. Two of them had no mutations
in their VIdCR genes and one had only a few (16, 21). One of these antibodies
is 36-65, the prototypical Id"", germline gene segment-encoded anti-Ars anti-
body (21). Antibody hVH65-205, which bound to DNA and cytoskeletal proteins,
is also of interest. Its VIdCR gene is not mutated and, in the panel we tested, it
is the only antibody obtained after immunization with Ars that does not react
with the hapten (T. Manser, unpublished data). Thus, of the 14 mAbs with
autoreactivity, 13 are encoded by an unmutated VIdcR gene, and in the 14th,
the same gene has only a few mutations.NAPARSTEK ET AL .
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Thereare several reasons why the resultsare due to immunochemically specific
binding of the antibodies and not to any ill-defined nonspecific sticky property
of IgM. First, reactions with DNA and cytoskeletal proteins were found with
both IgM and IgG antibodies ; furthermore, 10 of the 20 IgM antibodies from
A/J mice did not react in the autoantibody tests (Table 1) . The binding of the
anti-DNA antibodies only to certain polynucleotides in liquid-phase assays also
points to the specificity of the reactions . Both the inhibition ofDNA binding by
Ars-tyrosine (Fig. 3) and the loss of both ssDNA and Ars binding induced by
substitution of the serine residue in position 99 of the V region of36-65 indicate
that the DNA-binding site of the antibodies is related to the binding site for the
hapten conjugate . Finally, the inhibition of DNA binding by the monoclonal
anti-Id" (AD8) (Fig . 4) adds evidence that the variable region of the mAbs was
involved in the binding to DNA.
These results implicate the VIdcR-encoded heavy chain as the main contrib-
utor to the DNA-binding properties of the autoreactive antibodies in the panel
we tested . However, 3 of the 13 immunoglobulins encoded by the nonmutated
VId" gene did not bind DNA. Other portions of the antibody molecule
therefore influence the expression of its potential DNA-binding site . The hybri-
dornas were selected with a heavy chain-specific probe, and presumably ex-
pressed different light chains . Results of immunoblotting experiments with
electrophoretically separated heavy and light chains from VIdcR-encoded anti-
bodies are consistent with the interpretation that the heavy chain alone provides
a DNA-binding site, and that different light chains may either permit or hinder
expression of this site in the assembled molecule (Y . Naparstek and B. Ardman,
unpublished results) .
Even if we allow that anti-DNA antibodies are heterogeneous, and that by
chance alone some VIdIR-encoded antibodies should bind DNA, the proportion
of unmutated VIdCR gene-encoded antibodies that bound to DNA was high
(50%) . When randomly selected hybridomas from normal mice were screened
for anti-DNA activity, the frequency was lower, -10% (27) . The heavy chain
encoded by the unmutated VHdCR gene, therefore, appears to have a particular
preference for an epitope present in DNA and cytoskeletal proteins .
The polyreactivity ofanti-DNA mAbs has been attributed (28) to nonspecific
or weak interactions with polyanionic molecules . However, polyreactive mono-
clonal autoantibodies show immunochemical specificity : only certain helical or
single-stranded nucleic acid structures bind to mAb that react with multiple
polynucleotides (reviewed in 2) . The anti-DNA antibodies that bind to phospho-
lipids are inhibited by diphosphatidic acid, but not by phosphatidyl serine (5),
and specific polynucleotides displace the binding of polyreactive monoclonal
autoantibodies to cytoskeletal proteins (3) . Although ionic binding to polyanions
can be shown with a variety of different proteins (29), the conditions under
which we assayed anti-DNA activity (pH 7.2 or 8, ionic strength >0.1) minimize
nonspecific ionic interactions . Moreover, DNA binding occurs not only with
cationic Igs, but also with anionic antibodies having pIs as low as 5.3 (30) . Anti-
DNA antibodies that also bind toTNP do not bind to polyanions with repeating
charged units like chondroitin sulfate, keratosulfate, and RNA (9) . The anti-
DNA antibodies we tested also failed to bind to RNA, which is just as densely622
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charged as ssDNA . Nor did they register in ELISA assays with blank polystyrene
plates containing 3% BSA . The binding ofanti-DNA antibodies may involve not
only the charged surface of the polynucleotide (31), but also portions of specific
bases that protrude into the major or minor grooves of the molecule (32) . The
latter is an important factor in determining the selectivity ofthe bindingreactions
of polyreactive anti-DNA antibodies (2) . The ability of individual monoclonal
anti-DNA autoantibodies to bind to other, apparently unrelated autoantigens
(3-6) indicates that these apparently unrelated autoantigens must share certain
epitopes . These kinds of crossreactions in preimmune antibodies suggest that
autoantibodies that are generally considered to comprise distinctive, separate
groups may have a common origin in the germline .
The six A/J antibodies that bound to both Ars and DNA (Table I, groups II
and III) are of considerable interest . They are reminiscent of the mAbs that
react with both DNA and TNP, and of the rheumatoid factors that react with
both DNA and nitrophenyl hapten (8, 33-35, and reviewed in 2) . This kind of
dual antibody reactivity with DNA and exogenous antigens may seem strange,
but as we have shown here, and as others have also demonstrated (9), the binding
to DNA can be completely displaced by the synthetic hapten . The occurrence of
VnId`'R-encoded anti-DNA antibodies within the preimmune population, and of
VHIdCR-encoded antibodies that bind to both DNA and Ars (or only to Ars) in
the immune population suggests a sequence of events in which antibodies with
the dual reactivity occupy an intermediate position .
The panel of Id" mouse mAbs tested here is analogous to the family of
human antibodies that share the major crossreactive human idiotype termed
Id 16/6 (36) . Included in this family are autoantibodies that bind to DNA and
cytoskeletal proteins, the Waldenstrom's macroglobulins that bind to capsular
polysaccharides of Klebsiella pneumoniae, and still other macroglobulins that bind
both to the autoantigens and the bacterial antigens (8) . The first 40 amino-
terminal residues of the light chains of four antibodies of the Id11/6 family (16/6,
1/13b, 1/17, and 18/2), derived from differentpatients, are identical (37) . WEA,
a Waldenstrom's protein with the 16/6 idiotype, has a single substitution in that
region (38), and it binds to both DNA and a Klebsiella polysaccharide (8) .
Trepicchio and Barrette have pointed to the extensive structural homology of
the heavy chains of antibodies of the Id 16/6 family and Vn26, ahuman germline-
encoded Ig . These structural and immunochemical findings suggest that some
human autoantibodies, like the mouse antibodies described here, are part of the
preimmune repertoire, and that by somatic mutation of the V genes that encode
them, they acquire selective reactivity with exogenous (bacterial) antigens .
Our results support the hypothesis that autoantibodies are present in the
normal preimmune repertoire and are encoded by germline genes. The data
demonstrate directly that DNA-binding and anticytoskeletal activity occurs in
high frequency in the preimmune germline repertoire : 13 out of 26 antibodies
encoded by the unmutated VId`'R gene bound to DNA. The findings presented
here are consistent with other results suggesting a high frequency of autoanti-
s Trepicchio, W ., Jr ., and K . J . Barrett . 1986 . A panel of MRL/Ipr anti-DNA autoantibodies is
encoded by multiple V genes derived from four V gene families . Manuscript submitted for
publication .NAPARSTEK ET AL.
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bodies in the preimmune repertoire. 4-12% of hybridomas prepared from
newborn (26) or germ-free (39) mice have been found to produce autoantibodies
against DNA andcytoskeletal proteins, and about 6% ofhybridomas from young,
unimmunized mice produced antibodies reactive against pancreas, stomach,
salivary gland, and pituitary (40). We conclude, therefore, that germline genes
with the potential to encode autoantibodies occur in high frequency. This
conclusion is consistent with Jerne's hypothesis that the available immune re-
sponse repertoire is shaped by autoreactivity (41). It also appears that somatic
mutation in the presence of a foreign antigen, which acts as a selective agent,
can result in the loss of the autoantibody phenotype and a gain in reactivity
against the foreign antigen. Recently, Mahana et al. (42) have also proposed that
the antibody response to exogenous antigens originates from preimmune B cells
that produce natural autoantibodies; they too found dual binding specificities
(autoantigen/exogenous antigen) in mAbs derived from immunized mice.
Whether the antibodies described here represent the progenitors ofpathogenetic
antibodies remains an open question, but since their reactions with autoantigens
do not differ from those oftypical lupus autoantibodies (3, 14, 15) the possibility
now exists to trace the evolution ofpathogenetic autoantibodies from antibodies
encoded by the normal preimmune repertoire.
Summary
These experiments tested the hypothesis that unmutated germline genes from
normal mice can encode autoantibodies. We found that the unmutated VHId"
gene segment, which encodes a large proportion of antiarsonate antibodies in
A/J mice, also encodes antibodies with theability tobind to DNA and cytoskeletal
proteins. After Ars immunization, at a time when the VHIdcR gene segment
mutates and antibody affinity for the hapten increases, reactivity with the
autoantigens was lost. Six antibodies obtained afterimmunization with Ars bound
both the Ars and DNA. Results of competitive inhibition assays suggested that
the same variable region site in the antibodies bound to both Ars and DNA. The
properties ofthe individual germline-encoded antibodies, which include reactiv-
ity to both DNA and cytoskeletal proteins, suggest that autoantibodies charac-
teristic of SLE might be a subset of antibodies encoded by unmutated germline
V genes.
Receivedfor publication 18 February 1986 and in revisedform 28 April 1986.
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